← SynDRA
FH-535
SynDRA canonical compound SYN0078944 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | PPARD | PPARG |
|---|
| Mechanism of action | PPAR receptor antagonist | WNT signaling inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- PPAR receptor antagonist
- WNT signaling inhibitor
Cross-references
Synonyms
- FH535
- RefChem:140372
- DTXCID70343577
- 2,5-dichloro-N-(2-methyl-4-nitrophenyl)benzenesulfonamide
- N-(2-Methyl-4-nitrophenyl)-2,5-dichlorobenzenesulfonamide
- beta-Catenin/Tcf Inhibitor, FH535
- MFCD01212888
- 2,5-dichloro-N-(2-methyl-4-nitrophenyl)benzene-1-sulfonamide
- N-[2-methyl-4-nitrophenyl]-2,5-dichlorobenzenesulfonamide
- |A-Catenin/Tcf Inhibitor, FH535
- CBMicro_011295
- orb1305521
- SCHEMBL15318105
- SCHEMBL29351587
- EX-A388
- CHEBI:125569
- 2,5-dichloro-N-(2-methyl-4-nitrophenyl)-benzenesulfonamide
- GLXC-05502
- HMS3653N07
- SMSF0005619
- BDBM50509999
- FH535?
- HB0288
- NSC778746
- s7484
- STK079761
- AKOS003980135
- CB14399
- CCG-208119
- CS-1538
- NSC-778746
- SB19433
- AC-31439
- AS-60177
- DA-33629
- FH535, >=98% (HPLC)
- HY-15721
- BIM-0011242.P001
- SW219729-1
Look up FH-535 in the interactive SynDRA portal →